Abstract
The development of adjuvant arthritis induced important modifications in intracellular levels of cyclic AMP and GMP in primary and secondary lymphoid organs: a continuous decrease in cyclic AMP and a biphasic increase in the level of cyclic GMP which correlate well with the onset of the acute phase and the systemization of the disease.
Similar content being viewed by others
References
J.P. Giroud, D.A. Willoughby andC.J. Dunn,Interrelationship of Cyclic Nucleotides and Prostaglandins in the Inflammatory Process, Front. Matrix Biol.6, pp. 185–192 (Karger, Basel 1978).
J.P. Giroud, R. Bertin andR. Portet,In vivo Study of the Variations in Cyclic AMP and Cyclic GMP Levels in Complete Freund's Adjuvant-Induced Arthritis in the Rat, Biomedicine29, 309–311 (1978).
M.J. Parnham, I.L. Bonta andM.J.P. Adolfs,Cyclic AMP and Prostaglandin E in Perfusates of Rat Hind Paws during the Development of Adjuvant Arthritis, Ann. Rheum. Dis.37, 218–224 (1978).
H.L. Cailla, C.J. Vannier andM. Delaage, Guanosine 3′,5′ Cyclic Monophosphate Assay at 10−15 Mole Level, Anal. Biochem.70, 195–202 (1976).
H.L. Cailla, M.S. Racine-Weisbuch andM.A. Delaage, Adenosine 3′,5′ Cyclic Monophosphate Assay at 10−15 Mole Level, Anal. Biochem.56, 394–407 (1973).
A.L. Steiner, D.M. Kipnis, R. Utiger andC.W. Parker,Radioimmuno-assay for the Measurement of Adenosine 3′,5′ Cyclic Phosphate, Proc. natl. Acad. Sci. USA64, 367–373 (1969).
I. Yamamoto andD.R. Webb,Antigen-Stimulated Changes in Cyclic Nucleotide Levels in the Mouse, Proc. natl. Acad. Sci. USA72 (6), 2320–2324 (1975).
D.A. Deporter, P. Dieppe andD.A. Willoughby Pyrophosphate Induced Inflammation: An in vivo Study of the Interrelationship of Intracellular Cyclic AMP and Cyclic GMP, Agents and Actions6, 476–478 (1976).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tissot, M., Bertin, R., Portet, R. et al. Variations in levels of cyclic AMP and GMP in the thymus, spleen and mesenteric lymph node of rats after the induction of adjuvant arthritis. Agents and Actions 10, 563–565 (1980). https://doi.org/10.1007/BF02024167
Issue Date:
DOI: https://doi.org/10.1007/BF02024167